LGALS1 — MultiTargetDB

Summary

Top Co-occurrence Targets

InChIKey	pChEMBL	Type	Targets	Clinical
`HEAHGFKBVBBTBI`	9.4	IC50	2	—
`PAVDSVBSVHEIBU`	9.4	IC50	2	—
`KYJFFRQAMGUMCP`	9.4	IC50	2	—
`SVLRGJLTQRHIDZ`	9.4	IC50	2	—
`VKFLZPIQZLVZMK`	9.4	IC50	2	—
`NYISZEOSLITVEQ`	9.4	IC50	2	—
`JHGAFKHUAZYRCY`	9.3	IC50	2	—
`PFRRKTNFZPRAIP`	9.3	IC50	2	—
`XSEWYUCEDAKXBM`	9.3	IC50	2	—
`MWQPPBAGYPLFPF`	9.3	IC50	2	—
`NDCUFUOVKZGBTA`	9.3	IC50	2	—
`CIGFKUJDPVQRDL`	9.3	IC50	2	—
`WKGDSRNVPFGYFC`	9.3	IC50	2	—
`YDUXNTAFWMONEF`	9.3	IC50	2	—
`ISRCOHFBDUXZHC`	9.3	IC50	2	—
`NCVBLHFSOWJGRQ`	9.3	IC50	2	—
`FIDSLIVBNHTFSN`	9.3	IC50	2	—
`ZPCDJFVPZBVYMR`	9.3	IC50	2	—
`FEBOZTXMGQISPV`	9.2	IC50	2	—
`JFZMWODMJKOKPU`	9.2	IC50	2	—
`JSMROVHTKDYUEP`	9.2	IC50	2	—
`DOEAVJNELYUBKI`	9.2	IC50	2	—
`RTDBVNIEYVGLJM`	9.2	IC50	2	—
`MRXLXSNWYYFUEC`	9.2	IC50	2	—
`YQWJZVXKDNVWDR`	9.2	IC50	2	—
`BMWSZQJBMXPYMP`	9.2	IC50	2	—
`AWWFERVUYPYQOC`	9.1	IC50	2	—
`HUPILEYJTKHJLF`	9.1	IC50	2	—
`JFZMWODMJKOKPU`	9.1	IC50	2	—
`SQQXWIORNCMVFC`	9.1	IC50	2	—
`YZVQNPHRVLRRDY`	9.1	IC50	2	—
`CIGFKUJDPVQRDL`	9.1	IC50	2	—
`UHLDGZJBWVPCRD`	9.1	IC50	2	—
`UZDMVIUNPKRGLP`	9.1	IC50	2	—
`ZFIGVNHUYLRIOE`	9.1	IC50	2	—
`ADDKEMYLVVZXCK`	9.1	IC50	2	—
`BMWSZQJBMXPYMP`	9.1	IC50	2	—
`URWZOHIBOBOQHZ`	9.1	IC50	2	—
`NPPFBCQUOTZCEV`	9.1	IC50	2	—
`FCSHYQUVWRWERL`	9.1	IC50	2	—
`ISRCOHFBDUXZHC`	9.1	IC50	2	—
`RAMZTVDKTMXGGJ`	9.1	IC50	2	—
`OMTAZSIELSHOQY`	9.1	IC50	2	—
`OMTAZSIELSHOQY`	9.1	IC50	2	—
`ZFIGVNHUYLRIOE`	9.0	IC50	2	—
`YEHJXXJWSPGFEL`	9.0	IC50	2	—
`YEKATUZSHNIHKQ`	8.9	IC50	2	—
`RWVAINKLJZNRAP`	8.9	IC50	2	—
`URNHDQNEVNGJOB`	8.9	IC50	2	—
`FEBOZTXMGQISPV`	8.9	IC50	2	—